Upregulation of both C2 and Factor B seen at baseline in T2D may be responsible for the well described increased levels of C3 and C3 activator in diabetes that are related to glucose intolerance and elevated fasting plasma glucose [35]. This evidence concerns the gene C3 and type 2 diabetes mellitus.